Equate Beauty

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet, which is debossed with "A" on one side and "123" on the opposite side. Each tablet contains 500 mg of Acetaminophen. The formulation includes the following inactive ingredients: microcrystalline cellulose, croscarmellose sodium, magnesium stearate, povidone, talc, hypromellose, titanium dioxide, polyethylene glycol, iron oxide red, and iron oxide yellow.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic or nonteratogenic effects mentioned associated with its use.

Dosage and Administration

New users should initially apply the product to a small area of skin to test for sensitivity. If no discomfort occurs, the product may be applied to the affected area. Following application, it should be rinsed off as directed.

The recommended starting regimen involves one application per day. Based on individual response and as directed by a physician, the frequency may be gradually increased to 2-3 times daily.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should discontinue use and consult a healthcare professional if irritation, dryness, or redness develops and persists. Pregnant or breastfeeding individuals should seek medical advice prior to use. Direct contact with the eyes must be avoided; in the event of contact, the eyes should be rinsed thoroughly with water for 15 minutes. Additionally, individuals using other topical acne medications concurrently or immediately after applying this product should consult a healthcare provider or pharmacist before use.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from sources of heat or fire to prevent any risk of ignition.

Healthcare professionals should advise patients to consult with a doctor or pharmacist prior to using this product if they are concurrently using other topical acne medications. The combination of treatments may exacerbate skin dryness or irritation. In such cases, it is recommended that only one medication be utilized unless otherwise directed by a healthcare provider.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should discontinue use and consult a physician if they experience persistent irritation, dryness, or redness. Additionally, it is advisable for individuals who are pregnant or breastfeeding to seek medical advice before using this product.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and is flammable; therefore, it should be kept away from sources of heat or fire.

During use, patients should avoid contact with the eyes. In the event of contact, it is recommended to rinse the eyes thoroughly with water for at least 15 minutes.

Patients are advised to stop using the product and consult a doctor if they experience irritation, dryness, or redness that develops and persists. Additionally, it is important for patients to consult with a doctor or pharmacist before using this product if they are concurrently using other topical acne medications. The combination of these treatments may increase the risk of skin dryness or irritation. If such reactions occur, it is advised that only one medication be used unless otherwise directed by a healthcare professional.

Furthermore, patients who are pregnant or breastfeeding should seek medical advice before using this product to ensure safety for themselves and their child.

Drug Interactions

Concurrent use of this product with other topical acne medications may lead to increased dryness or irritation of the skin. It is advisable for patients to consult with a healthcare professional, such as a doctor or pharmacist, prior to using this product alongside other topical acne treatments. In cases where increased dryness or irritation is experienced, it is recommended that only one medication be utilized unless otherwise directed by a healthcare provider. Monitoring for skin reactions is advised to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Beauty (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

Before using this product, pediatric patients or their caregivers should consult a healthcare professional if other topical acne medications are being used concurrently or immediately after application. The combination may lead to increased dryness or irritation of the skin; in such cases, only one medication should be utilized unless otherwise directed by a physician.

For new users, it is advised to apply the product to a small area to test for sensitivity prior to full application. If no discomfort is experienced, the product can be applied to the affected area and rinsed off. Treatment should begin with one application, which may be gradually increased to 2-3 times daily as needed or as directed by a physician.

Geriatric Use

Elderly patients may not have specific information regarding the use of EQUATE BEAUTY - salicylic acid soap, as the drug insert does not provide details on dosage adjustments, safety concerns, or special precautions for this population.

Healthcare providers should exercise caution when recommending this product to geriatric patients, considering the absence of data on its effects and safety in this age group. Monitoring for any adverse reactions or sensitivities is advisable, given the potential for altered pharmacokinetics and increased susceptibility to side effects in elderly individuals.

Pregnancy

Pregnant patients and those who are breastfeeding should consult their healthcare provider before using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult their healthcare provider before using this medication while breastfeeding. There is no specific data available regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to mitigate potential risks associated with overdosage.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Monitoring for any adverse effects is essential, and appropriate management should be initiated based on the clinical presentation.

Management procedures may include supportive care and symptomatic treatment as necessary. It is recommended that healthcare providers remain vigilant and prepared to implement interventions tailored to the specific circumstances of the overdosage incident.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed to discontinue use and consult a doctor if they experience irritation, dryness, or redness that persists. Additionally, it is important to ask patients if they are pregnant or breastfeeding before recommending the use of this product.

When using this product, patients should be cautioned to avoid contact with the eyes. In case of contact, they should rinse their eyes thoroughly with water for at least 15 minutes.

Healthcare providers should also recommend that patients consult with their doctor or pharmacist before using this product if they are currently using other topical acne medications. The concurrent use of multiple topical treatments may increase the risk of skin dryness or irritation. If such effects occur, patients should be advised to use only one medication unless otherwise directed by a healthcare professional.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The product is administered topically. New users are advised to apply it to a small area to test for sensitivity; if no discomfort occurs, they may apply it to the affected area and rinse off. Initial use should begin with one application, which can be gradually increased to 2-3 times daily as needed or as directed by a physician.

Clinicians should counsel patients to consult a doctor or pharmacist before using this product concurrently with other topical acne medications, as this may exacerbate skin dryness or irritation. Patients should discontinue use and seek medical advice if they experience persistent irritation, dryness, or redness. Additionally, it is important to consult a healthcare professional if pregnant or breastfeeding. The product should be kept out of reach of children, and in the event of accidental ingestion, medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Equate Beauty, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)